{"id":18556,"date":"2026-04-23T15:23:31","date_gmt":"2026-04-23T08:23:31","guid":{"rendered":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/?p=18556"},"modified":"2026-05-28T12:04:14","modified_gmt":"2026-05-28T05:04:14","slug":"mau-muc-tieu-nghe-nghiep-duoc-si","status":"publish","type":"post","link":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/tu-van-nghe-nghiep\/mau-muc-tieu-nghe-nghiep-duoc-si","title":{"rendered":"M\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 \u2013 c\u00e1ch vi\u1ebft trong CV theo c\u1ea5p b\u1eadc"},"content":{"rendered":"

D\u01b0\u1ee3c s\u0129 (Pharmacist) l\u00e0 v\u1ecb tr\u00ed then ch\u1ed1t trong h\u1ec7 th\u1ed1ng ch\u0103m s\u00f3c s\u1ee9c kho\u1ebb, h\u00e0nh ngh\u1ec1 t\u1ea1i nh\u00e0 thu\u1ed1c, b\u1ec7nh vi\u1ec7n, c\u00f4ng ty d\u01b0\u1ee3c v\u00e0 c\u01a1 quan qu\u1ea3n l\u00fd. Theo d\u1eef li\u1ec7u CareerLink (05\/2026), chuy\u00ean m\u1ee5c D\u01b0\u1ee3c \u2013 Sinh h\u1ecdc \u0111ang c\u00f3 kho\u1ea3ng 527 tin tuy\u1ec3n d\u1ee5ng, trong \u0111\u00f3 5 v\u1ecb tr\u00ed ph\u1ed5 bi\u1ebfn g\u1ed3m d\u01b0\u1ee3c s\u0129 nh\u00e0 thu\u1ed1c, d\u01b0\u1ee3c l\u00e2m s\u00e0ng, QA\/QC d\u01b0\u1ee3c, \u0111\u0103ng k\u00fd thu\u1ed1c v\u00e0 tr\u00ecnh d\u01b0\u1ee3c vi\u00ean. M\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129<\/strong> chu\u1ea9n n\u0103m 2026 c\u1ea7n ph\u00e2n bi\u1ec7t r\u00f5 c\u1ea5p b\u1eadc (fresher \u2013 senior \u2013 manager) v\u00e0 ph\u00e2n kh\u00fac h\u00e0nh ngh\u1ec1 \u0111\u1ec3 g\u00e2y \u1ea5n t\u01b0\u1ee3ng \u0111\u00fang \u0111\u1ed1i t\u01b0\u1ee3ng tuy\u1ec3n d\u1ee5ng.<\/p>\n

\"\"<\/figure>\n
\n

T\u1ed5ng quan nhanh:<\/strong><\/p>\n

\u2013 M\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u00e0i 3\u20135 d\u00f2ng, \u0111\u1eb7t sau th\u00f4ng tin c\u00e1 nh\u00e2n, tr\u01b0\u1edbc ph\u1ea7n kinh nghi\u1ec7m.<\/p>\n

\u2013 C\u1ea7n \u0111\u1ec1 c\u1eadp ch\u1ee9ng ch\u1ec9 h\u00e0nh ngh\u1ec1 d\u01b0\u1ee3c (CCHND) theo Lu\u1eadt D\u01b0\u1ee3c 105\/2016\/QH13 v\u00e0 c\u00e1c ti\u00eau chu\u1ea9n GPP, GSP, GMP-WHO n\u1ebfu ph\u00f9 h\u1ee3p.<\/p>\n

\u2013 M\u1ee9c l\u01b0\u01a1ng tham kh\u1ea3o d\u01b0\u1ee3c s\u0129 2026: fresher 9\u201314 tri\u1ec7u, c\u00f3 2\u20134 n\u0103m kinh nghi\u1ec7m 16\u201325 tri\u1ec7u, senior\/QA 25\u201340 tri\u1ec7u (theo d\u1eef li\u1ec7u CRL Q2\/2026, top khu v\u1ef1c: H\u1ea3i Ph\u00f2ng, TP.HCM, \u0110\u1ed3ng Nai, H\u00e0 N\u1ed9i, B\u1eafc Ninh).<\/p>\n

\u2013 B\u00e0i t\u1ed5ng h\u1ee3p 8 m\u1eabu m\u1ee5c ti\u00eau th\u1ef1c t\u1ebf theo c\u1ea5p b\u1eadc v\u00e0 ph\u00e2n kh\u00fac h\u00e0nh ngh\u1ec1 kh\u00e1c nhau.<\/p>\n<\/div>\n

1. Ph\u00e2n lo\u1ea1i m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 theo ph\u00e2n kh\u00fac h\u00e0nh ngh\u1ec1<\/h2>\n

D\u01b0\u1ee3c s\u0129 c\u00f3 nhi\u1ec1u ng\u1ea3 ph\u00e1t tri\u1ec3n \u2013 m\u1ed7i ng\u1ea3 y\u00eau c\u1ea7u k\u1ef9 n\u0103ng v\u00e0 ch\u1ee9ng ch\u1ec9 kh\u00e1c nhau. M\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p vi\u1ebft theo c\u00f4ng th\u1ee9c “t\u00f4i mu\u1ed1n tr\u1edf th\u00e0nh d\u01b0\u1ee3c s\u0129 gi\u1ecfi” s\u1ebd thi\u1ebfu s\u1ee9c n\u1eb7ng. H\u00e3y x\u00e1c \u0111\u1ecbnh tr\u01b0\u1edbc ph\u00e2n kh\u00fac \u0111ang \u1ee9ng tuy\u1ec3n: nh\u00e0 thu\u1ed1c, b\u1ec7nh vi\u1ec7n, c\u00f4ng nghi\u1ec7p d\u01b0\u1ee3c, marketing pharma hay qu\u1ea3n l\u00fd nh\u00e0 n\u01b0\u1edbc.<\/p>\n\n\n\n\n\n\n\n\n\n\n
Ph\u00e2n kh\u00fac<\/th>\nY\u00eau c\u1ea7u ch\u1ee9ng ch\u1ec9 ch\u00ednh<\/th>\nKPI\/Ch\u1ec9 s\u1ed1 tr\u1ecdng t\u00e2m<\/th>\nL\u01b0\u01a1ng tham kh\u1ea3o (tri\u1ec7u\/th\u00e1ng)<\/th>\n<\/tr>\n<\/thead>\n
D\u01b0\u1ee3c s\u0129 nh\u00e0 thu\u1ed1c<\/td>\nCCHND + GPP<\/td>\nS\u1ed1 \u0111\u01a1n\/ng\u00e0y, doanh thu\/ca, t\u01b0 v\u1ea5n ADR<\/td>\n9\u201318<\/td>\n<\/tr>\n
D\u01b0\u1ee3c l\u00e2m s\u00e0ng (B\u1ec7nh vi\u1ec7n)<\/td>\nCCHND + ch\u1ee9ng ch\u1ec9 l\u00e2m s\u00e0ng\/CME<\/td>\nS\u1ed1 ph\u00e1c \u0111\u1ed3 tham gia, can thi\u1ec7p l\u00e2m s\u00e0ng<\/td>\n12\u201328<\/td>\n<\/tr>\n
QA\/QC nh\u00e0 m\u00e1y GMP<\/td>\nCCHND + GMP-WHO + ISO 9001<\/td>\nS\u1ed1 deviation, CAPA, t\u1ef7 l\u1ec7 pass batch<\/td>\n15\u201335<\/td>\n<\/tr>\n
\u0110\u0103ng k\u00fd thu\u1ed1c (RA)<\/td>\nCCHND + ASEAN CTD\/eCTD<\/td>\nS\u1ed1 h\u1ed3 s\u01a1 n\u1ed9p, th\u1eddi gian \u0111\u01b0\u1ee3c duy\u1ec7t<\/td>\n18\u201340<\/td>\n<\/tr>\n
Tr\u00ecnh d\u01b0\u1ee3c vi\u00ean ETC\/OTC<\/td>\nCCHND (khuy\u1ebfn kh\u00edch) + Pharma Sales<\/td>\n% \u0111\u1ea1t KPI doanh s\u1ed1, s\u1ed1 visit\/tu\u1ea7n<\/td>\n10\u201330 + th\u01b0\u1edfng<\/td>\n<\/tr>\n
Marketing Pharma<\/td>\nCCHND + Mini MBA\/Brand Mgmt<\/td>\nMarket share, A&P efficiency<\/td>\n22\u201350<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Tham kh\u1ea3o c\u00e1c tin tuy\u1ec3n d\u1ee5ng \u0111a d\u1ea1ng ng\u00e0nh D\u01b0\u1ee3c t\u1ea1i chuy\u00ean m\u1ee5c D\u01b0\u1ee3c \u2013 Sinh h\u1ecdc<\/a> tr\u00ean CareerLink \u0111\u1ec3 hi\u1ec3u y\u00eau c\u1ea7u c\u1ee5 th\u1ec3 t\u1eebng ph\u00e2n kh\u00fac tr\u01b0\u1edbc khi ch\u1ed1t m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p.<\/p>\n

Tham kh\u1ea3o th\u00eam b\u00e0i vi\u1ebft v\u1ec1 d\u01b0\u1ee3c s\u0129 l\u00e0 g\u00ec \u2013 c\u00f4ng vi\u1ec7c v\u00e0 k\u1ef9 n\u0103ng c\u1ea7n c\u00f3<\/a> \u0111\u1ec3 c\u00f3 c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 l\u0129nh v\u1ef1c v\u00e0 l\u1ed9 tr\u00ecnh ph\u00e1t tri\u1ec3n ngh\u1ec1 nghi\u1ec7p t\u01b0\u01a1ng \u1ee9ng.<\/p>\n

2. C\u1ea5u tr\u00fac m\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 chu\u1ea9n<\/h2>\n

M\u1ed9t m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 \u0111\u1ea1t chu\u1ea9n n\u00ean tu\u00e2n theo c\u1ea5u tr\u00fac 3 l\u1edbp: hi\u1ec7n tr\u1ea1ng \u2013 cam k\u1ebft ng\u1eafn h\u1ea1n \u2013 \u0111\u1ecbnh h\u01b0\u1edbng d\u00e0i h\u1ea1n. L\u1edbp hi\u1ec7n tr\u1ea1ng n\u00eau b\u1eb1ng c\u1ea5p, ch\u1ee9ng ch\u1ec9 v\u00e0 kinh nghi\u1ec7m c\u1ed1t l\u00f5i. L\u1edbp cam k\u1ebft ng\u1eafn h\u1ea1n (6\u201312 th\u00e1ng) g\u1eafn v\u1edbi KPI c\u1ee5 th\u1ec3 c\u1ee7a ph\u00e2n kh\u00fac \u0111ang \u1ee9ng tuy\u1ec3n. L\u1edbp \u0111\u1ecbnh h\u01b0\u1edbng d\u00e0i h\u1ea1n (3\u20135 n\u0103m) th\u1ec3 hi\u1ec7n t\u1ea7m nh\u00ecn ph\u00e1t tri\u1ec3n trong ng\u00e0nh.<\/p>\n

\u2013 Hi\u1ec7n tr\u1ea1ng:<\/strong> \u0110\u1ea1i h\u1ecdc\/Cao \u0111\u1eb3ng D\u01b0\u1ee3c, n\u0103m t\u1ed1t nghi\u1ec7p, GPA, CCHND (n\u1ebfu c\u00f3), kinh nghi\u1ec7m th\u1ef1c t\u1eadp\/\u0111i l\u00e0m.<\/p>\n

\u2013 Cam k\u1ebft ng\u1eafn h\u1ea1n:<\/strong> Doanh s\u1ed1 th\u00e1ng (cho nh\u00e0 thu\u1ed1c), s\u1ed1 ca l\u00e2m s\u00e0ng tham gia (cho b\u1ec7nh vi\u1ec7n), s\u1ed1 deviation\/CAPA x\u1eed l\u00fd (cho QA), s\u1ed1 h\u1ed3 s\u01a1 \u0111\u0103ng k\u00fd (cho RA).<\/p>\n

\u2013 \u0110\u1ecbnh h\u01b0\u1edbng d\u00e0i h\u1ea1n:<\/strong> L\u00ean Senior, Tr\u01b0\u1edfng nh\u00f3m, Qu\u1ea3n l\u00fd ho\u1eb7c chuy\u1ec3n sang chuy\u00ean m\u00f4n cao h\u01a1n (D\u01b0\u1ee3c l\u00e2m s\u00e0ng c\u1ea5p II, MSL, Regulatory Manager).<\/p>\n

Tr\u00e1nh vi\u1ebft ki\u1ec3u kh\u1ea9u hi\u1ec7u: “\u0111am m\u00ea ch\u0103m s\u00f3c s\u1ee9c kho\u1ebb”, “c\u1ed1ng hi\u1ebfn cho ng\u00e0nh Y” m\u00e0 kh\u00f4ng c\u00f3 h\u00e0nh vi c\u1ee5 th\u1ec3 \u0111i k\u00e8m. Nh\u00e0 tuy\u1ec3n d\u1ee5ng d\u01b0\u1ee3c \u01b0u ti\u00ean \u1ee9ng vi\u00ean th\u1ec3 hi\u1ec7n t\u01b0 duy c\u00f3 ch\u1ec9 ti\u00eau, c\u00f3 l\u1ed9 tr\u00ecnh.<\/p>\n

3. M\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 theo c\u1ea5p b\u1eadc v\u00e0 ph\u00e2n kh\u00fac<\/h2>\n

T\u1ed5ng h\u1ee3p 8 m\u1eabu th\u1ef1c t\u1ebf \u0111\u00e3 \u0111\u01b0\u1ee3c ch\u1ec9nh ph\u00f9 h\u1ee3p th\u1ecb tr\u01b0\u1eddng Vi\u1ec7t Nam 2026. \u1ee8ng vi\u00ean n\u00ean thay s\u1ed1 li\u1ec7u c\u1ee7a b\u1ea3n th\u00e2n v\u00e0o v\u00e0 \u0111i\u1ec1u ch\u1ec9nh cho t\u1eebng c\u00f4ng ty c\u1ee5 th\u1ec3.<\/p>\n

M\u1eabu 1 \u2013 Fresher d\u01b0\u1ee3c s\u0129 nh\u00e0 thu\u1ed1c:<\/strong><\/p>\n

\n

C\u1eed nh\u00e2n D\u01b0\u1ee3c \u0110\u1ea1i h\u1ecdc Y D\u01b0\u1ee3c TP.HCM 2026 (GPA 3.3\/4.0), \u0111\u00e3 ho\u00e0n th\u00e0nh 4 th\u00e1ng th\u1ef1c t\u1eadp t\u1ea1i nh\u00e0 thu\u1ed1c Pharmacity v\u00e0 2 th\u00e1ng t\u1ea1i Long Ch\u00e2u. M\u1ee5c ti\u00eau trong 6 th\u00e1ng \u0111\u1ea7u: t\u01b0 v\u1ea5n 60\u201380 \u0111\u01a1n\/ng\u00e0y t\u1ea1i nh\u00e0 thu\u1ed1c Q.7, duy tr\u00ec tu\u00e2n th\u1ee7 to\u00e0n b\u1ed9 quy tr\u00ecnh GPP. \u0110\u1ecbnh h\u01b0\u1edbng 3 n\u0103m: tr\u1edf th\u00e0nh Pharmacist Manager ph\u1ee5 tr\u00e1ch 2\u20133 chi nh\u00e1nh v\u00e0 \u0111\u00e0o t\u1ea1o d\u01b0\u1ee3c s\u0129 m\u1edbi.<\/p>\n<\/blockquote>\n

M\u1eabu 2 \u2013 Fresher d\u01b0\u1ee3c l\u00e2m s\u00e0ng (b\u1ec7nh vi\u1ec7n):<\/strong><\/p>\n

\n

D\u01b0\u1ee3c s\u0129 \u0110\u1ea1i h\u1ecdc ch\u00ednh quy v\u1edbi 3 th\u00e1ng th\u1ef1c t\u1eadp Khoa D\u01b0\u1ee3c B\u1ec7nh vi\u1ec7n Ch\u1ee3 R\u1eaby. \u0110ang ch\u1edd thi c\u1ea5p ch\u1ee9ng ch\u1ec9 h\u00e0nh ngh\u1ec1 d\u01b0\u1ee3c. Mong mu\u1ed1n \u1ee9ng tuy\u1ec3n v\u1ecb tr\u00ed D\u01b0\u1ee3c l\u00e2m s\u00e0ng t\u1ea1i b\u1ec7nh vi\u1ec7n h\u1ea1ng 1, tham gia h\u1ed9i ch\u1ea9n 5\u20138 ca\/tu\u1ea7n v\u00e0 x\u00e2y d\u1ef1ng t\u00e0i li\u1ec7u h\u01b0\u1edbng d\u1eabn s\u1eed d\u1ee5ng thu\u1ed1c cho \u0111i\u1ec1u d\u01b0\u1ee1ng. L\u1ed9 tr\u00ecnh 5 n\u0103m: D\u01b0\u1ee3c l\u00e2m s\u00e0ng c\u1ea5p II, chuy\u00ean s\u00e2u nh\u00f3m kh\u00e1ng sinh \u2013 ch\u1ed1ng \u0111\u00f4ng.<\/p>\n<\/blockquote>\n

M\u1eabu 3 \u2013 Fresher QA\/QC nh\u00e0 m\u00e1y GMP-WHO:<\/strong><\/p>\n

\n

T\u1ed1t nghi\u1ec7p \u0110\u1ea1i h\u1ecdc D\u01b0\u1ee3c H\u00e0 N\u1ed9i 2026, c\u00f3 6 th\u00e1ng th\u1ef1c t\u1eadp t\u1ea1i Nh\u00e0 m\u00e1y D\u01b0\u1ee3c H\u1eadu Giang (\u0111\u1ea1t chu\u1ea9n GMP-WHO). M\u1ee5c ti\u00eau trong n\u0103m \u0111\u1ea7u: th\u00e0nh th\u1ea1o SOP cho 3 d\u00e2y chuy\u1ec1n vi\u00ean n\u00e9n \u2013 vi\u00ean nang \u2013 siro, h\u1ed7 tr\u1ee3 ki\u1ec3m so\u00e1t \u2264 0.5% deviation\/th\u00e1ng. \u0110\u1ecbnh h\u01b0\u1edbng d\u00e0i h\u1ea1n: chuy\u00ean gia Validation thu\u1ed9c nh\u00f3m QA, h\u01b0\u1edbng t\u1edbi ch\u1ee9ng ch\u1ec9 Six Sigma Green Belt v\u00e0 ISO 9001 Lead Auditor.<\/p>\n<\/blockquote>\n

M\u1eabu 4 \u2013 C\u00f3 kinh nghi\u1ec7m 2 n\u0103m d\u01b0\u1ee3c s\u0129 nh\u00e0 thu\u1ed1c, \u0111\u1ecbnh h\u01b0\u1edbng chuy\u1ec3n sang chu\u1ed7i:<\/strong><\/p>\n

\n

D\u01b0\u1ee3c s\u0129 v\u1edbi 2 n\u0103m kinh nghi\u1ec7m t\u1ea1i nh\u00e0 thu\u1ed1c t\u01b0 nh\u00e2n qu\u1eadn 11, doanh s\u1ed1 trung b\u00ecnh 220 tri\u1ec7u\/th\u00e1ng. \u0110\u00e3 c\u00f3 CCHND s\u1ed1\u2026 do S\u1edf Y t\u1ebf TP.HCM c\u1ea5p 2024. Mong mu\u1ed1n chuy\u1ec3n sang v\u1ecb tr\u00ed D\u01b0\u1ee3c s\u0129 tr\u01b0\u1edfng t\u1ea1i chu\u1ed7i Long Ch\u00e2u\/Pharmacity \u0111\u1ec3 h\u1ec7 th\u1ed1ng ho\u00e1 quy tr\u00ecnh t\u01b0 v\u1ea5n theo SOP. Cam k\u1ebft duy tr\u00ec doanh thu 300 tri\u1ec7u\/th\u00e1ng v\u00e0 \u0111\u00e0o t\u1ea1o 2\u20133 d\u01b0\u1ee3c s\u0129 m\u1edbi trong n\u0103m \u0111\u1ea7u.<\/p>\n<\/blockquote>\n

M\u1eabu 5 \u2013 Senior d\u01b0\u1ee3c l\u00e2m s\u00e0ng 4 n\u0103m:<\/strong><\/p>\n

\n

D\u01b0\u1ee3c s\u0129 l\u00e2m s\u00e0ng v\u1edbi 4 n\u0103m kinh nghi\u1ec7m Khoa D\u01b0\u1ee3c B\u1ec7nh vi\u1ec7n B\u1ea1ch Mai, tham gia h\u1ed9i ch\u1ea9n 250+ ca\/n\u0103m thu\u1ed9c nh\u00f3m h\u1ed3i s\u1ee9c v\u00e0 b\u1ec7nh truy\u1ec1n nhi\u1ec5m. \u0110\u00e3 ho\u00e0n th\u00e0nh ch\u1ee9ng ch\u1ec9 Pharmacotherapy Advanced (H\u1ed9i D\u01b0\u1ee3c l\u00e2m s\u00e0ng VN 2025). M\u1ee5c ti\u00eau: chuy\u1ec3n sang v\u1ecb tr\u00ed Medical Science Liaison (MSL) t\u1ea1i MNC nh\u00f3m Anti-Infective, t\u1eadn d\u1ee5ng kinh nghi\u1ec7m l\u00e2m s\u00e0ng v\u00e0 m\u1ea1ng l\u01b0\u1edbi quan h\u1ec7 v\u1edbi 40+ b\u00e1c s\u0129 chuy\u00ean khoa.<\/p>\n<\/blockquote>\n

M\u1eabu 6 \u2013 \u0110\u0103ng k\u00fd thu\u1ed1c (RA) c\u00f3 3 n\u0103m kinh nghi\u1ec7m:<\/strong><\/p>\n

\n

Regulatory Affairs Specialist v\u1edbi 3 n\u0103m kinh nghi\u1ec7m t\u1ea1i c\u00f4ng ty d\u01b0\u1ee3c Vi\u1ec7t \u2013 \u0111\u00e3 n\u1ed9p 18 h\u1ed3 s\u01a1 ASEAN CTD v\u00e0 4 h\u1ed3 s\u01a1 eCTD \u0111\u0103ng k\u00fd m\u1edbi. T\u1ef7 l\u1ec7 duy\u1ec7t th\u1eb3ng 78%, kh\u00f4ng c\u00f3 h\u1ed3 s\u01a1 ph\u1ea3i n\u1ed9p b\u1ed5 sung qu\u00e1 2 l\u1ea7n. M\u1ee5c ti\u00eau chuy\u1ec3n sang c\u00f4ng ty \u0111a qu\u1ed1c gia (MNC) ph\u1ee5 tr\u00e1ch nh\u00f3m s\u1ea3n ph\u1ea9m sinh h\u1ecdc, theo h\u1ecdc ch\u1ee9ng ch\u1ec9 RAPS Online (06\/2026). \u0110\u1ecbnh h\u01b0\u1edbng 5 n\u0103m: Regulatory Manager khu v\u1ef1c ASEAN.<\/p>\n<\/blockquote>\n

M\u1eabu 7 \u2013 Marketing Pharma chuy\u1ec3n t\u1eeb Med Rep:<\/strong><\/p>\n

\n

Senior Medical Representative v\u1edbi 5 n\u0103m t\u1ea1i Sanofi v\u00e0 Pfizer Vietnam, \u0111\u1ea1t 105\u2013112% ch\u1ec9 ti\u00eau doanh s\u1ed1 16 qu\u00fd li\u00ean ti\u1ebfp. \u0110\u00e3 ho\u00e0n th\u00e0nh Mini MBA UEH 2025 v\u00e0 ch\u1ee9ng ch\u1ec9 Brand Management (HBR Online). M\u1ee5c ti\u00eau chuy\u1ec3n sang v\u1ecb tr\u00ed Product Executive\/Brand Manager Junior cho nh\u00f3m Cardio \u2013 Diabetes, t\u1eadp trung ph\u00e1t tri\u1ec3n chi\u1ebfn l\u01b0\u1ee3c digital marketing cho b\u00e1c s\u0129 (HCP digital). \u0110\u1ecbnh h\u01b0\u1edbng 5 n\u0103m: Group Brand Manager.<\/p>\n<\/blockquote>\n

M\u1eabu 8 \u2013 Qu\u1ea3n l\u00fd nh\u00e0 n\u01b0\u1edbc (S\u1edf Y t\u1ebf, C\u1ee5c Qu\u1ea3n l\u00fd D\u01b0\u1ee3c):<\/strong><\/p>\n

\n

D\u01b0\u1ee3c s\u0129 chuy\u00ean khoa I v\u1edbi 7 n\u0103m kinh nghi\u1ec7m t\u1ea1i C\u1ee5c Qu\u1ea3n l\u00fd D\u01b0\u1ee3c, tham gia th\u1ea9m \u0111\u1ecbnh 60+ h\u1ed3 s\u01a1 \u0111\u0103ng k\u00fd m\u1edbi v\u00e0 bi\u00ean so\u1ea1n 4 d\u1ef1 th\u1ea3o Th\u00f4ng t\u01b0 h\u01b0\u1edbng d\u1eabn. M\u1ee5c ti\u00eau trong 12 th\u00e1ng: ho\u00e0n th\u00e0nh ch\u1ee9ng ch\u1ec9 chuy\u00ean khoa II, tham gia t\u1ed5 c\u00f4ng t\u00e1c c\u1ea3i c\u00e1ch th\u1ee7 t\u1ee5c \u0111\u0103ng k\u00fd thu\u1ed1c theo Ngh\u1ecb \u0111\u1ecbnh 88\/2023\/N\u0110-CP. \u0110\u1ecbnh h\u01b0\u1edbng d\u00e0i h\u1ea1n: chuy\u00ean gia th\u1ea9m \u0111\u1ecbnh c\u1ea5p cao thu\u1ed9c H\u1ed9i \u0111\u1ed3ng T\u01b0 v\u1ea5n c\u1ea5p gi\u1ea5y \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh thu\u1ed1c.<\/p>\n<\/blockquote>\n

\n

“M\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p t\u1ed1t nh\u1ea5t l\u00e0 m\u1ee5c ti\u00eau khi\u1ebfn nh\u00e0 tuy\u1ec3n d\u1ee5ng t\u1ef1 h\u1ecfi: \u1ee9ng vi\u00ean n\u00e0y ph\u00f9 h\u1ee3p \u1edf v\u1ecb tr\u00ed n\u00e0o trong 3 n\u0103m t\u1edbi c\u1ee7a t\u00f4i. N\u1ebfu m\u1ee5c ti\u00eau ch\u1ec9 n\u00f3i chung chung ‘ph\u00e1t tri\u1ec3n ngh\u1ec1 nghi\u1ec7p’, c\u00e2u tr\u1ea3 l\u1eddi s\u1ebd l\u00e0 ‘kh\u00f4ng bi\u1ebft \u2013 next CV’.” \u2013 Tr\u01b0\u1edfng ph\u00f2ng tuy\u1ec3n d\u1ee5ng m\u1ed9t c\u00f4ng ty d\u01b0\u1ee3c \u0111a qu\u1ed1c gia t\u1ea1i TP.HCM.<\/p>\n<\/blockquote>\n

\n

L\u1ed7i c\u1ea7n tr\u00e1nh khi vi\u1ebft m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129:<\/strong><\/p>\n

\u2013 Sao ch\u00e9p nguy\u00ean m\u1eabu tr\u00ean m\u1ea1ng, kh\u00f4ng c\u00e1 nh\u00e2n ho\u00e1 \u2013 nh\u00e0 tuy\u1ec3n d\u1ee5ng \u0111\u1ecdc 50\u2013100 CV\/tu\u1ea7n d\u1ec5 nh\u1eadn ra.<\/p>\n

\u2013 B\u1ecf qua ch\u1ee9ng ch\u1ec9 h\u00e0nh ngh\u1ec1 d\u01b0\u1ee3c \u2013 Lu\u1eadt D\u01b0\u1ee3c 105\/2016\/QH13 quy \u0111\u1ecbnh CCHND l\u00e0 \u0111i\u1ec1u ki\u1ec7n h\u00e0nh ngh\u1ec1 \u0111\u1ed9c l\u1eadp.<\/p>\n

\u2013 Cam k\u1ebft KPI phi th\u1ef1c t\u1ebf (“\u0111\u1ea1t 200% target trong 3 th\u00e1ng \u0111\u1ea7u”) \u2013 ng\u00e0nh d\u01b0\u1ee3c coi tr\u1ecdng t\u00ednh ch\u00ednh tr\u1ef1c v\u00e0 b\u1ec1n v\u1eefng.<\/p>\n

\u2013 Vi\u1ebft qu\u00e1 d\u00e0i (tr\u00ean 6 d\u00f2ng) \u2013 m\u1ee5c ti\u00eau l\u00e0 ph\u1ea7n m\u1edf, kh\u00f4ng ph\u1ea3i to\u00e0n b\u1ed9 CV.<\/p>\n<\/div>\n

4. C\u00e1ch tu\u1ef3 ch\u1ec9nh m\u1ee5c ti\u00eau cho t\u1eebng c\u00f4ng ty<\/h2>\n

M\u1ed9t m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p t\u1ed1t n\u00ean \u0111\u01b0\u1ee3c \u0111i\u1ec1u ch\u1ec9nh t\u1ed1i thi\u1ec3u 25\u201330% cho t\u1eebng c\u00f4ng ty c\u1ee5 th\u1ec3. C\u1ea7n nghi\u00ean c\u1ee9u tr\u01b0\u1edbc 3 y\u1ebfu t\u1ed1 tr\u01b0\u1edbc khi vi\u1ebft: (1) danh m\u1ee5c s\u1ea3n ph\u1ea9m ch\u1ee7 l\u1ef1c c\u1ee7a c\u00f4ng ty, (2) v\u0103n ho\u00e1 doanh nghi\u1ec7p (MNC truy\u1ec1n th\u1ed1ng, c\u00f4ng ty Vi\u1ec7t n\u0103ng \u0111\u1ed9ng, hay startup pharma-tech), (3) l\u1ed9 tr\u00ecnh th\u0103ng ti\u1ebfn \u0111i\u1ec3n h\u00ecnh.<\/p>\n

\u2013 V\u1edbi MNC (Sanofi, Pfizer, GSK, Roche, Novartis, MSD):<\/strong> Nh\u1ea5n m\u1ea1nh t\u00ednh ch\u00ednh tr\u1ef1c, tu\u00e2n th\u1ee7 quy chu\u1ea9n qu\u1ed1c t\u1ebf (IFPMA Code), kh\u1ea3 n\u0103ng \u0111\u1ecdc ti\u1ebfng Anh chuy\u00ean ng\u00e0nh.<\/p>\n

\u2013 V\u1edbi c\u00f4ng ty Vi\u1ec7t (Traphaco, DHG, Imexpharm, Mediplantex):<\/strong> Nh\u1ea5n m\u1ea1nh kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng n\u1ed9i \u0111\u1ecba, hi\u1ec3u v\u0103n ho\u00e1 ti\u00eau d\u00f9ng VN.<\/p>\n

\u2013 V\u1edbi chu\u1ed7i nh\u00e0 thu\u1ed1c (Long Ch\u00e2u, Pharmacity, An Khang):<\/strong> Nh\u1ea5n m\u1ea1nh k\u1ef9 n\u0103ng v\u1eadn h\u00e0nh SOP, doanh s\u1ed1\/ca v\u00e0 t\u01b0 v\u1ea5n kh\u00e1ch h\u00e0ng.<\/p>\n

\u2013 V\u1edbi startup pharma-tech (Jio Health, Doctor Anywhere):<\/strong> Nh\u1ea5n m\u1ea1nh kh\u1ea3 n\u0103ng t\u01b0 v\u1ea5n telehealth, s\u1eed d\u1ee5ng ph\u1ea7n m\u1ec1m EMR\/EHR.<\/p>\n

\n

L\u1eddi khuy\u00ean cho d\u01b0\u1ee3c s\u0129 mu\u1ed1n n\u00e2ng c\u1ea5p CV:<\/strong><\/p>\n

\u2013 Ho\u00e0n th\u00e0nh ch\u1ee9ng ch\u1ec9 Pharmacotherapy ho\u1eb7c Pharmaceutical Care (H\u1ed9i D\u01b0\u1ee3c h\u1ecdc VN, ASHP) \u2013 t\u0103ng gi\u00e1 tr\u1ecb cho d\u01b0\u1ee3c l\u00e2m s\u00e0ng.<\/p>\n

\u2013 H\u1ecdc th\u00eam ch\u1ee9ng ch\u1ec9 Six Sigma Yellow\/Green Belt n\u1ebfu h\u01b0\u1edbng QA\/QC \u2013 ng\u00e0y c\u00e0ng nhi\u1ec1u nh\u00e0 m\u00e1y GMP y\u00eau c\u1ea7u.<\/p>\n

\u2013 \u0110\u0103ng k\u00fd Coursera Pharmaceutical R&D ho\u1eb7c edX Drug Discovery cho h\u01b0\u1edbng nghi\u00ean c\u1ee9u\/\u0111\u0103ng k\u00fd thu\u1ed1c.<\/p>\n

\u2013 C\u1eadp nh\u1eadt CME 48 gi\u1edd\/2 n\u0103m theo Th\u00f4ng t\u01b0 22\/2013\/TT-BYT \u0111\u1ec3 duy tr\u00ec CCHND.<\/p>\n<\/div>\n

5. C\u00e2u h\u1ecfi th\u01b0\u1eddng g\u1eb7p<\/h2>\n

1. Sinh vi\u00ean d\u01b0\u1ee3c n\u0103m cu\u1ed1i ch\u01b0a c\u00f3 CCHND c\u00f3 n\u00ean ghi m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p \u1edf v\u1ecb tr\u00ed d\u01b0\u1ee3c s\u0129 chuy\u00ean m\u00f4n?<\/em><\/strong><\/p>\n

C\u00f3. H\u00e3y n\u00eau r\u00f5 “\u0111ang trong giai \u0111o\u1ea1n th\u1ef1c h\u00e0nh 9 th\u00e1ng \u0111\u1ec3 thi CCHND theo Lu\u1eadt D\u01b0\u1ee3c 105\/2016\/QH13”. \u0110a s\u1ed1 b\u1ec7nh vi\u1ec7n v\u00e0 c\u00f4ng ty d\u01b0\u1ee3c ch\u1ea5p nh\u1eadn tuy\u1ec3n d\u01b0\u1ee3c s\u0129 ch\u01b0a c\u00f3 CCHND nh\u01b0ng cam k\u1ebft ho\u00e0n th\u00e0nh trong 12 th\u00e1ng. M\u1ee5c ti\u00eau n\u00ean k\u00e8m th\u00f4ng tin: tr\u01b0\u1eddng \u0111\u00e0o t\u1ea1o, GPA, c\u01a1 s\u1edf th\u1ef1c t\u1eadp v\u00e0 l\u0129nh v\u1ef1c mu\u1ed1n theo \u0111u\u1ed5i.<\/p>\n

2. M\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p c\u00f3 c\u1ea7n ghi m\u1ee9c l\u01b0\u01a1ng k\u1ef3 v\u1ecdng kh\u00f4ng?<\/em><\/strong><\/p>\n

Kh\u00f4ng. L\u01b0\u01a1ng k\u1ef3 v\u1ecdng n\u00ean \u0111\u1eb7t m\u1ee5c ri\u00eang (Expected Salary) ho\u1eb7c trao \u0111\u1ed5i trong bu\u1ed5i ph\u1ecfng v\u1ea5n. M\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u00f9ng \u0111\u1ec3 thuy\u1ebft ph\u1ee5c nh\u00e0 tuy\u1ec3n d\u1ee5ng v\u1ec1 n\u0103ng l\u1ef1c v\u00e0 \u0111\u1ecbnh h\u01b0\u1edbng, kh\u00f4ng ph\u1ea3i \u0111\u1ec3 \u0111\u00e0m ph\u00e1n. \u0110\u1ec1 c\u1eadp l\u01b0\u01a1ng trong m\u1ee5c ti\u00eau d\u1ec5 t\u1ea1o c\u1ea3m gi\u00e1c \u1ee9ng vi\u00ean xem tr\u1ecdng ti\u1ec1n h\u01a1n c\u01a1 h\u1ed9i h\u1ecdc h\u1ecfi \u2013 m\u1ed9t \u0111i\u1ec3m tr\u1eeb v\u1edbi nhi\u1ec1u nh\u00e0 tuy\u1ec3n d\u1ee5ng d\u01b0\u1ee3c, \u0111\u1eb7c bi\u1ec7t MNC.<\/p>\n

3. D\u01b0\u1ee3c s\u0129 chuy\u1ec3n ng\u00e0nh sang ph\u00e2n kh\u00fac kh\u00e1c (nh\u00e0 thu\u1ed1c \u2192 b\u1ec7nh vi\u1ec7n) vi\u1ebft m\u1ee5c ti\u00eau th\u1ebf n\u00e0o?<\/em><\/strong><\/p>\n

M\u1ee5c ti\u00eau n\u00ean gi\u1ea3i th\u00edch l\u00fd do chuy\u1ec3n ng\u00e0nh ng\u1eafn g\u1ecdn (1 c\u00e2u) v\u00e0 nh\u1ea5n m\u1ea1nh k\u1ef9 n\u0103ng c\u00f3 th\u1ec3 chuy\u1ec3n giao. V\u00ed d\u1ee5: “Sau 3 n\u0103m t\u01b0 v\u1ea5n h\u01a1n 60 \u0111\u01a1n\/ng\u00e0y t\u1ea1i nh\u00e0 thu\u1ed1c, t\u00f4i mu\u1ed1n \u00e1p d\u1ee5ng kinh nghi\u1ec7m t\u01b0\u01a1ng t\u00e1c b\u1ec7nh nh\u00e2n v\u00e0 am hi\u1ec3u c\u00e1c nh\u00f3m thu\u1ed1c OTC v\u00e0o vai tr\u00f2 D\u01b0\u1ee3c l\u00e2m s\u00e0ng t\u1ea1i b\u1ec7nh vi\u1ec7n h\u1ea1ng 2, t\u1eadp trung t\u01b0 v\u1ea5n an to\u00e0n d\u00f9ng thu\u1ed1c cho ng\u01b0\u1eddi cao tu\u1ed5i.” C\u00e1ch n\u00e0y th\u1ec3 hi\u1ec7n s\u1ef1 chuy\u1ec3n d\u1ecbch c\u00f3 l\u1ed9 tr\u00ecnh thay v\u00ec nh\u1ea3y vi\u1ec7c thi\u1ebfu \u0111\u1ecbnh h\u01b0\u1edbng.<\/p>\n

Vi\u1ebft t\u1ed1t m\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129<\/strong> d\u1ef1a tr\u00ean 3 nguy\u00ean t\u1eafc: ph\u00e2n bi\u1ec7t r\u00f5 ph\u00e2n kh\u00fac (nh\u00e0 thu\u1ed1c\/l\u00e2m s\u00e0ng\/QA\/RA\/marketing), g\u1eafn KPI v\u00e0 ch\u1ee9ng ch\u1ec9 c\u1ee5 th\u1ec3 theo Lu\u1eadt D\u01b0\u1ee3c 105\/2016\/QH13, v\u00e0 c\u00e1 nh\u00e2n ho\u00e1 cho t\u1eebng c\u00f4ng ty \u1ee9ng tuy\u1ec3n. M\u1ee5c ti\u00eau s\u00fac t\u00edch nh\u01b0ng c\u00f3 d\u1eef li\u1ec7u s\u1ebd t\u1ea1o \u1ea5n t\u01b0\u1ee3ng m\u1ea1nh h\u01a1n c\u00e1c \u0111o\u1ea1n m\u00f4 t\u1ea3 chung chung. H\u00e3y c\u1eadp nh\u1eadt m\u1ee5c ti\u00eau m\u1ed7i 12 th\u00e1ng \u0111\u1ec3 ph\u1ea3n \u00e1nh ch\u1ee9ng ch\u1ec9 m\u1edbi, kinh nghi\u1ec7m m\u1edbi v\u00e0 tham v\u1ecdng ngh\u1ec1 nghi\u1ec7p \u0111\u00e3 tr\u01b0\u1edfng th\u00e0nh.<\/p>\n

B\u00e0i vi\u1ebft mang t\u00ednh ch\u1ea5t tham kh\u1ea3o, kh\u00f4ng thay th\u1ebf t\u01b0 v\u1ea5n ngh\u1ec1 nghi\u1ec7p chuy\u00ean s\u00e2u t\u1eeb chuy\u00ean gia ng\u00e0nh d\u01b0\u1ee3c.<\/em><\/p>\n

Minh An<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

T\u1ed5ng h\u1ee3p m\u1eabu m\u1ee5c ti\u00eau ngh\u1ec1 nghi\u1ec7p d\u01b0\u1ee3c s\u0129 theo t\u1eebng c\u1ea5p b\u1eadc fresher, mid-level, senior. H\u01b0\u1edbng d\u1eabn c\u00e1ch vi\u1ebft n\u1ed5i b\u1eadt trong CV xin vi\u1ec7c ng\u00e0nh D\u01b0\u1ee3c.<\/p>\n","protected":false},"author":58,"featured_media":18602,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-18556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tu-van-nghe-nghiep"],"_links":{"self":[{"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/posts\/18556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/users\/58"}],"replies":[{"embeddable":true,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/comments?post=18556"}],"version-history":[{"count":6,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/posts\/18556\/revisions"}],"predecessor-version":[{"id":22350,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/posts\/18556\/revisions\/22350"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/media\/18602"}],"wp:attachment":[{"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/media?parent=18556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/categories?post=18556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mb668s.com\/cam-nang-7mb66-xoc-dia\/wp-json\/wp\/v2\/tags?post=18556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}